Cancer News and Research

Latest Cancer News and Research

Scientists identify the IL-17 protein as a determining factor in skin aging

Scientists identify the IL-17 protein as a determining factor in skin aging

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

National experts explore public health information system's strengths, weaknesses, opportunities and threats

National experts explore public health information system's strengths, weaknesses, opportunities and threats

Damon Runyon and St. Jude announce a new pediatric-focused fellowship

Damon Runyon and St. Jude announce a new pediatric-focused fellowship

Teaming up with the patient’s immune system to combat cancer

Teaming up with the patient’s immune system to combat cancer

Massage therapists ease the pain of hospice patients — but aren’t easy to find

Massage therapists ease the pain of hospice patients — but aren’t easy to find

Pneumothorax prevalence in COVID-19 and influenza patients

Pneumothorax prevalence in COVID-19 and influenza patients

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

What was the prevalence of germline genetic testing among patients diagnosed with cancer in California and Georgia between 2013 and 2019?

Assessing the role of Docetaxel post-chemoimmunotherapy for patients with NSCLC

Assessing the role of Docetaxel post-chemoimmunotherapy for patients with NSCLC

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

Scientists uncover key molecular culprit in ALS: PEG10 gene implicated in pathogenesis

Scientists uncover key molecular culprit in ALS: PEG10 gene implicated in pathogenesis

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

UVA scientists discover a key determinant of multiple sclerosis risk

UVA scientists discover a key determinant of multiple sclerosis risk

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

Study: Functional limitations among US cancer survivors more than doubled over the past 20 years

DNAmFitAge: A new method to incorporate physical fitness into epigenetic clocks

DNAmFitAge: A new method to incorporate physical fitness into epigenetic clocks

New insights into how aggressive cancer cells proliferate and propagate the disease

New insights into how aggressive cancer cells proliferate and propagate the disease

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

Participation in physical activity should be promoted in those with high genetic risk of type two diabetes

Participation in physical activity should be promoted in those with high genetic risk of type two diabetes

Differences in tumor mutation burden are a major reason for divergence: Study

Differences in tumor mutation burden are a major reason for divergence: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.